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Abstract 
Imaging of joints with 2D radiography has not been able to detect therapeutic 
success in research trials while 3D imaging, used regularly in the clinic, has not 
been approved for this purpose. We present a new 3D approach to this challenge 
called joint space mapping (JSM) that measures joint space width in 3D from 
standard clinical computed tomography (CT) data, demonstrating its analysis 
steps, technical validation, and reproducibility. Using high resolution peripheral 
quantitative CT as gold standard, we show a marginal over-estimation in accuracy 
of +0.13 mm and precision of ±0.32 mm. Inter-operator reproducibility bias was 
near-zero at -0.03 mm with limits of agreement ±0.29 mm and a root mean square 
coefficient of variation 7.5%. In a technical advance, we present results from 
across the hip joint in 3D with optimum validation and reproducibility metrics 
shown at inner joint regions. We also show JSM versatility using different imaging 
data sets and discuss potential applications. This 3D mapping approach provides 
information with greater sensitivity than reported for current radiographic methods 
that could result in improved patient stratification and treatment monitoring.  
 
MAIN TEXT 
 
Introduction 
Joint diseases such as osteoarthritis, inflammatory arthritis, and gout are 
estimated to affect 25% of the US population, making them a leading cause of 
morbidity and poor quality of life from painful loss of function1. These diseases will 
become an increasingly important clinical challenge as populations grow and 
become proportionally older. Imaging plays a key role alongside clinical review of 
patients with joint disease because it can depict individual joint involvement while 
avoiding the need for invasive tissue sampling2. It can also be used repeatedly 
and safely within recognised limits, which is important for follow-up of these 
chronic conditions. Yet our ability to detect structural changes that can identify 
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disease early, monitor progression, and predict treatment response has been 
frustratingly limited.  
Radiography, magnetic resonance imaging (MRI), and ultrasound are the 
accepted standards for imaging assessment of joint disease and have been the 
preferred modalities for joint imaging in clinical research trials. The use of 
radiography is near universal (see below), while MRI has commonly been 
performed in assessment of cartilage, e.g. looking for thinning in osteoarthritis3, 
and ultrasound in assessment of joint inflammation, e.g. in rheumatoid arthritis4. 
However, the US Food and Drug Administration (FDA) has to date only approved 
2D radiographic joint space assessment for clinical trial imaging endpoints5,6.  
For osteoarthritis, the most common joint disease, this endpoint is defined as 
progression in 2D radiographic joint space narrowing that requires manual 
measurement of joint space width and a new definition of progression for each 
study. This is also the OARSI-OMERACT recommendation for setting 
osteoarthritis clinical trial endpoints7,8. Subjective semi-quantitative Kellgren and 
Lawrence (K&L) radiographic grading has also been widely used, but this has 
been shown to suffer from multiple varied definitions and problematic reliability9,10. 
Other similar radiographic scores have been applied in the assessment of 
rheumatoid arthritis11, but these have failed to demonstrate structural damage 
adequately because of limitations in analysis methods6.  
Therapeutic trials have been described as being “in desperate need” of reliable 
biomarkers for optimising the chance of successful outcomes. While there has 
been some promise from compositional MRI techniques, links between disease 
and parameters such as T2, T1rho, ultrashort echo and dGEMRIC times are yet to 
be clearly established12,13. No single imaging biomarker has proved outstanding.  
These modalities continue to be instrumental in the assessment of joint disease, 
yet there has also been growing support for the use of computed tomography (CT) 
in this role, mainly because of its strength in visualisation of mineralised joint 
tissues, rapid acquisition time, and 3D reconstruction capabilities14,15. This may in 
part be from recognising the value that 3D visualisation of bone has in 
understanding joint morphology and pre-operative planning16,17.  
If we take 2D radiographic joint space narrowing as the recognised surrogate 
marker for structural disease progression, it seems logical, although not foregone, 
that a 3D technique may yield information more representative of joint phenotype 
and disease status; CT works well in 3D because of its ability to reconstruct data 
volumes from helical data acquisitions. In this paper we consider a new 3D 
approach to analysis of CT imaging data in terms of identifying structural joint 
space changes. Before we do this, however, it is important to understand what 
technical challenges need to be overcome for success with a 3D imaging strategy.  
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Making accurate measurements in any imaging data requires understanding of 
the limits to image resolution. Imaging system blur, which sets this limit, is usually 
modelled as a point spread function (PSF) with a Gaussian profile. For CT, 
multiple factors such as detector size, physical properties of the system, and 
image reconstruction techniques all contribute to this blur, reducing capability to 
depict structures accurately. Put simply, features of a thickness below the image 
resolution limit are blurred and cannot be measured accurately. Modern CT 
imaging systems can be adapted to optimise image resolution. However, 
substantial increases in spatial resolution are only achieved at the cost of 
increased noise unless radiation dose is also increased, which is undesirable.  
Unfortunately, joint space widths are frequently below this feature size, hence the 
need to remove of image system blur for accurate measurement. This can be 
achieved with a constrained deconvolution approach, where the constraint (in this 
case prior knowledge of bone density around the joint space) acts to limit noise in 
measurement while still improving accuracy. In order to work in a 3D imaging 
framework, this process must be repeated at multiple locations and in multiple 
directions. Furthermore, this technique requires validation so that it can be trusted.  
3D joint space width measurement using CT technology has precedents: two 
techniques have been described in the context of rheumatoid arthritis using high 
resolution peripheral quantitative CT (HR-pQCT)18,19. However these techniques 
were restricted to small joints of the hand and cannot be transferred to larger 
joints such as the knee or hip because of their limited field of view (FOV) and 
radiation dose restrictions. Furthermore, quantified results were not presented in 
3D, nor were they validated against a gold standard with higher spatial resolution 
to establish their accuracy and precision. 
There are known limitations to operator-dependent interpretation of radiographs 
and manual measurement of joint space width. Therefore we propose a new 
quantitative 3D approach to evaluating joints as an alternative. We present a new 
semi-automatic image analysis technique called joint space mapping (JSM) that 
uses routine clinical CT imaging data to deliver 3D joint space width maps of 
human joints. We propose the utility of CT data, analysed via JSM, in predicting 
disease status by first demonstrating technical validation and interoperator 
reproducibility at the hip joint, then versatility across several joints. This new 
approach also forms the basis for wider applications that we discuss. 
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Results  
3D joint space patch creation 
Assessment of joint space width in 3D requires a framework on which to perform 
each deconvolution-based measurement. Fig. 1 shows the steps we take to 
deliver this framework, called the “joint space patch”, summarised here:  
(1) Acquisition of axial clinical CT imaging data, in this case with 1.5 mm 
reconstructed slice thickness, 0.31 x 0.31 mm pixel spacing, and a smooth post-
processing reconstruction kernel, all standard clinical acquisition parameters;  
(2) In-frame bone segmentation: we perform this manually (~5 minutes per 
femur), but this could alternatively be performed with an automatic segmentation 
technique20,21;   
(3) Automatic formation of a triangulated mesh and surface representation of the 
proximal femur22; 
(4) Automatic projection of acetabular bone onto the proximal femoral surface 
using the 3D imaging data volume;  
(5) Femoral surface review with freehand multiplanar reformatting (MPR) guiding 
manual segmentation of the joint space margin on the femoral surface (~2 
minutes per femur); then  
(6) Automatic extraction of the joint space patch along this boundary from the 
surface of the femur for subsequent data sampling in 3D. 
Steps 4 and 5 are the novel processing stages that are unique to the JSM 
algorithm. In step 4, the highest CT data value (in Hounsfield units, HU) sampled 
through the 3D data volume within ~5mm along a normal to each vertex in the 
proximal femoral mesh is projected back onto the proximal femur surface. This 
means a bright patch appears on the femur where there is opposing acetabular 
bone, and a dark patch where there is only soft tissue. The edge of this bright 
patch is confirmed as the margin of the joint space by reviewing the relationship 
between the femur and the acetabulum with a 3D MPR tool in step 5, followed by 
manual segmentation of the joint space boundary on the proximal femoral surface 
(Fig. 1 and Fig. S1). 
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Fig. 1. Joint space patch. Creation of the “joint space patch” from clinical CT imaging 
using Stradwin software. We perform manual segmentation of the proximal femur 
(step 2) taking ~5 minutes per femur, but this can be supplemented by automatic 
segmentation. This leaves segmentation of the joint space patch along the joint 
space margin on the femoral surface as the only other manual step, taking ~2 
minutes per femur. Fig. S1 shows a magnified view of step 5. 
 
All post-processing steps (2-6) are performed in Stradwin, software developed in 
house this is freely available to download and use 
(http://mi.eng.cam.ac.uk/~rwp/stradwin/). Full details of CT image acquisition and 
analysis steps are in the Materials and Methods section. 
3D joint space data sampling 
The extracted joint space patch is now ready to use as the framework for the next 
steps, noting that this process does not rely on any prior segmentation of the 
acetabular or femoral articular surfaces. First we estimate the peak cortical 
density of bone in HU from the image volume across the original proximal femoral 
mesh and assume that this is a fixed peak value across the joint space patch, as 
per the technique implemented by Treece et al.23. We then sample again through 
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the imaging data volume, but this time only at the vertices in the joint space patch 
mesh. Each 1D sample line arising perpendicular to a vertex results in an 
interpolated linear density profile. We assume that the image system blur along 
the line can be modelled as Gaussian in shape, though the extent of this blur is 
allowed to vary at each vertex. Surrounding bone is modelled as a double-peak24, 
each peak representing an opposing bone surface at the joint space (hence initial 
femur segmentation is only a guide). An optimiser fits a blurred model to the 
interpolated line data at each vertex, then blur is removed in the deconvolution 
step using a fixed peak density constraint to determine bone edges as step 
functions in the line data. The distance between the outer bone edges is delivered 
as the joint space width. Importantly, this process only requires the original femur 
segmentation to be within ± 2 mm of the proximal femoral surface25, meaning that 
small variations, whether from manual or automatic segmentation, are well 
tolerated and have a negligible effect on resultant joint space width values.  The 
difference between the original joint space patch extracted from the femoral 
surface and the JSM output femoral and acetabular surfaces is show in Fig. S2. 
After automatic outlier removal and data smoothing, 3D joint space width is 
mapped across the joint space patch in colour, a process that can also produce a 
3D joint space object. These steps are all automatic and shown in Fig. 2 as the 
JSM (blue) pathway, described fully in the Materials and Methods section.   
 
 
Fig. 2. 3D data sampling across the joint space. JSM (blue) and HR-JSM (orange) 
pathways for 3D joint space width measurement and validation. Joint space 
volume is delimited by the femoral and acetabular bone surfaces. While the HR-
JSM pathway requires cross-registration of the clinical CT and HRpQCT image 
volumes and manual outlier removal, these are only required for the validation 
study. All steps in the JSM pathway are fully automated. 
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JSM technical validation study setup 
A main aim of this study was to demonstrate that JSM can deliver accurate and 
precise measurements of joint space width in 3D. In order to achieve this, we 
validated joint space width values from clinical CT against high resolution 
peripheral QCT (HRpQCT) of the same cadaveric hip specimens. Since the use of 
cadaveric tissue removed restrictions on ionising radiation, we could use an 
HRpQCT image system with a PSF at least 10 times better than the clinical CT 
system, allowing a simpler adaptive threshold approach to measure the distance 
between outer bone surfaces as joint space width in the HRpQCT data26.This 
process is shown in Fig. 2 as the HR-JSM (orange) pathway. 
Each dissected cadaveric hip was scanned in a custom-designed acrylic holder to 
maintain fixed positioning between clinical CT and HRpQCT acquisitions. Clinical 
CT was performed as above, described in further detail in the Materials and 
Methods section. HRpQCT voxels were reconstructed isotropically at 0.082 mm 
with a proprietary post-processing bone algorithm (Scanco Medical AG, 
Brüttisellen, Switzerland). We then cross-registered clinical CT and HRpQCT 
image volumes using mutual information similarity intensity-based registration so 
that the joint space patch from the clinical CT data was correctly aligned in the 
HRpQCT image volume from the same hip27.  
Joint space width was then measured automatically across the patch with the HR-
JSM adaptive threshold technique. Technical failures causing abnormally low or 
misplaced values from noise in the HRpQCT imaging data were removed using 
an in-house custom MATLAB GUI. Clinical CT and HRpQCT values were 
subtracted from each other across the ~65,000 matching vertices out of ~74,000 
total over the 20 joint space patches to give accuracy and precision metrics. Here 
we use the term accuracy to represent mean bias as the mean of the absolute 
difference between the JSM measure and HRpQCT gold standard, and precision 
to represent the standard deviation of the difference between these two measures 
(i.e the standard deviation of the bias).  
We registered each acetabular surface to an average acetabular surface, allowing 
us to compare data from different subjects on the same framework (NB this is not 
the same surface as the original joint space patch cut from the proximal femur). 
Results from across all specimens could then be presented on this average 
surface in 3D. Full details of the clinical CT and HRpQCT acquisition, image set 
cross-registration, registration to the average surface, and validation steps are 
given in the Material and Methods section. 
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JSM technical validation study results 
Global accuracy of JSM (mean bias across all joint space measurements) was 
+0.13 mm, a slight overestimation compared to the high resolution technique. 
Global precision (standard deviation of the bias across all joint space 
measurements) was ±0.32 mm. Fig. 3a presents this data as clinical CT versus 
HRpQCT data, showing a slight overestimation bias at lower joint space width 
values. Fig. S3 shows the full HRpQCT validation data in a scatterplot. 
Breakdown to individual validation plots (not shown) revealed that a few hip joints 
with lower joint space width ranges were the cause of this bias. Fig. 3b shows 
mean clinical CT joint space width values from all samples on the average 
surface, revealing posterior joint space as narrowest at ~2.5 mm compared to a 
ceiling value of ~4 mm at the superior and anterior joint regions.  
Fig. 3c shows the vertex-by-vertex 3D distribution of accuracy and precision on 
the average surface, revealing slight underestimation to -0.2 mm at the superior 
joint space and more generalised overestimation to +0.2 mm in the anterior and 
posterior joint space. Largest bias was seen at the outer edges where values 
reach +0.5 mm, with precision ranging from 0.2-0.5 mm around the joint. 
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Fig. 3. Technical validation study results. a Clinical CT vs HRpQCT validation data 
presented in 0.2 mm HRpQCT bins with the median and centile values. The “true” 
line represents the target of equal 1.5 mm CT and HRpQCT measurement (i.e. no 
measurement bias). Outside the 95% data limits, the bin counts drop rapidly 
towards zero; b 3D distribution of average joint space width across the validation 
study group mapped onto the average acetabular surface; c 3D distribution of 
vertex-by-vertex validation data mapped onto the average surface as accuracy 
(clinical CT minus HRpQCT, top row) and precision (bottom row). 
 
JSM reproducibility study 
Another aim of this study was to show that novel components of the JSM 
algorithm were reliable between operators of the manual steps. In order to do this 
we compared the output of two operators (T.D.T., creator of the technique, and 
R.H., a graduate student trained in the technique) performing blinded analysis of 
30 hip joints with JSM. Proximal femurs in these data sets had already been 
manually segmented for a separate study, meaning that segmentation technique 
was not a variable factor28. All 30 hips were female with no previously known hip 
disease, but a mixture of side, severity of degenerative joint disease, and clinical 
CT acquisition parameters. This heterogeneity was intended to maximally test 
interoperator reproducibility. The acetabular surface output from each interaction 
was registered to the average surface so that results could also be presented in 
3D. Full details of these steps are in the Materials and Methods section. 
Global interobserver reproducibility bias calculated as the mean of the difference 
between the two operators was excellent at -0.03 mm, with limits of agreement 
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±0.40 mm (Bland-Altman plot, Fig. 4a), with a root mean square coefficient of 
variation (RMSCV) of 7.5%. Fig. 4b shows the 3D distribution of these results 
mapped on the average surface, showing near uniform reproducibility bias around 
a zero value, with a few edge locations where the highest reproducibility bias 
values were ~0.2 mm. Limits of agreement were at best less than 0.2 mm in the 
central joint space, rising to 0.8 mm at some of the joint space margin; 95% of 
these values were less than 0.67 mm. RMSCV followed a very similar 3D pattern 
to limits of agreement, with lowest values in the central joint space around 2.5% 
with some inner regions increasing to 10%, reaching maximum values of 15-20% 
in only a few marginal joint space regions; 95% of RMSCV values were less than 
12.9%. These worse interoperator reproducibility values are where we have 
already shown JSM to have least accuracy (Fig. 3c), likely from variability 
between users in joint space margin definition (step 5).  
 
 
Fig. 4. Reproducibility study results.	a Bland-Altman interoperator reproducibility plot 
as operator 1 (R.H.) minus operator 2 (T.D.T) showing the mean reproducibility 
bias (solid red line) and limits of agreement (1.96 x SD of the reproducibility bias, 
dashed red lines); b 3D distribution of reproducibility bias, limits of agreement, and 
RMSCV mapped onto the average surface.  
 
Heterogeneity in the reproducibility cohort also allowed us to show performance of 
JSM in extremes of radiographic disease. Fig. 5 emphasises JSM robustness by 
showing output in one individual with a radiographic K&L grade of 0 (no disease) 
and minimum 2D joint space width of 2.0 mm, the other with a radiographic K&L 
grade of 3 (moderate disease) and minimum 2D joint space width of 0 mm. 
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Fig. 5. JSM performance at the extremes of disease. Joint space margin are shown in 
green as seen in axial, coronal and sagittal planes (left to right) at two left hips: a 
An individual with a radiographic K&L grade of 0 (no disease) and minimum joint 
space width of 2.0 mm; b An individual with a radiographic K&L grade of 3 
(moderate disease) and minimum joint space width of 0 mm. This demonstrates 
that JSM is still able to represent joint space width as it approaches zero, 
important for analysis in advanced disease. 
 
Discussion  
In this paper we have presented a new semi-automatic image analysis technique 
called joint space mapping (JSM) that measures joint space width in 3D from 
routine clinical CT imaging data. We have shown it to be accurate and precise 
when validated against HRpQCT imaging, and robust in performance for different 
disease severities, scanning conditions, and joint locations. 
The systematic but slight overestimation of joint space width (globally +0.13 mm) 
compared to the gold standard appeared to be skewed by a few hips with lower 
joint space width values. We believe this effect was from a generalised lower 
cortical bone density at the joint space than estimated across the whole proximal 
femur, and found that automatic bone density estimation at the joint space was 
too low in this small number of subjects. However we opted to accept this small 
overestimation bias for automation of this step, also meaning that individuals with 
low bone density (e.g. osteoporosis) would not be excluded from successful joint 
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space mapping. Despite this, our accuracy is still below the in-plane pixel spacing 
of 0.31 mm, and substantially below the out-of-plane slice thickness of 1.5 mm. 
We recognise that error in the validation process is compounded from the JSM, 
HR-JSM and the image cross-registration steps. Bearing this is mind, our 
validation results show a global precision of ±0.32 mm, with best precision values 
around 0.2 mm in the inner joint space regions, which can be considered excellent 
precision for this multi-step process. 
We have demonstrated an inter-operator reproducibility bias of near zero (-0.03 
m), with best limits of agreement (also known as smallest detectable difference) 
achieved to less than 0.2 mm at the inner joint space regions, which are likely to 
be the most important in terms of detecting disease-relevant joint space 
narrowing. These values of less than 0.2 mm are superior to the reported best of 
0.45 mm for 2D radiographic joint space width assessment at the hip and 0.2 mm 
reported at the knee7,29. RMSCV values followed the same pattern, with best 
results of ~2.5% in the central joint space, and 95% of values less than 12.9%.  
Although the validation range is presented as 1.56 to 4.54 mm, we were simply 
limited by the range of joint space widths in our validation samples. Any 
measurement problem solved by deconvolution has a lower threshold below 
which resolution cannot be achieved, but we are encouraged by successful 
performance of JSM in an individual with a minimum radiographic joint space 
width of zero (Fig. 5). There is also no technical reason why JSM shouldn’t 
perform as well at values above this range.  
We also recognise the importance of consistent joint positioning when comparing 
joint space width values in 2D or 3D. A radiographic study by Goker et al. (2005) 
showed that although changing from neutral positioning to 30° of flexion at the hip 
had a significant effect on radiographic joint space width (increasing by 0.15 mm), 
there was no statistically significant difference between neutral and 15° flexion30. 
This means that small variations in hip joint position may not have a significant 
effect. Tom et al. (2016) also recently showed that metacarpophalangeal joint 
positioning had little effect on mean joint space width when repositioned at 20° 
intervals, with RMSCV values less than 5%31. 
Furthermore, although gold standard assessment of radiographic hip joint space 
width in clinical trials is performed in the standing position, several studies have 
shown no significant difference in radiographic joint space width values when 
supine compared to standing,32. It will be an important next step to use JSM to 
investigate whether differences in positioning and load-bearing have any effect on 
joint space width in 3D. A straightforward solution for prospective studies would be 
to perform knee and ankle CT in a standing position (as used in clinical practice), 
and to standardise of supine hip positioning by strapping feet together.  
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We can also show proof-of-concept that JSM has versatility to be applied at 
different joints with a range of acquisition and reconstruction conditions (Fig. 6). 
When higher resolution 3D imaging is achievable at more peripheral joints, such 
as the knee, hands or feet, then an adaptive threshold technique (as for HR-JSM) 
could be used rather than a deconvolution approach (Fig. 6b).  
 
 
 
Fig. 6. JSM at different joints. Feasibility of JSM application at various joints of the 
lower limb with different acquisition and reconstruction settings. Colour maps are 
displayed on the original patches in situ on the bone surfaces with joint space 
volumes inset in yellow. 
 
Even though JSM sensitivity appears better than the reported current radiographic 
gold standard, using surface-based statistical analysis on JSM output could yield 
even greater sensitivity. Another important JSM output is the 3D joint surface on 
which joint space width values are displayed, subsequently allowing surface-
based statistical analysis to be performed with statistical parametric mapping 
(SPM)33, the feasibility and success of which have already been demonstrated 
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with cortical bone mapping at the hip34,35. An important benefit of SPM is the 
avoidance of region of interest (ROI) or sub-ROI averaging of values as a single 
test variable, as is usually performed with MRI parameters such as cartilage 
thickness and compositional data3,36. Using an average surface to analyse data 
with SPM also brings versatility to what can be tested because there are no 
restrictions on side (as data can be mirrored), follow-up of an individual, or 
comparing data across whole study groups. Sensitivity to change, i.e. what can be 
detected as significant against noise, is also a product of the SPM process. This 
means that the reproducibility bias and limits of agreement presented here would 
not be the whole picture because SPM can reveal systematic differences in data 
to a level well below the sensitivity limits of a measurement method.  
Limitations on the use of CT from concerns over exposure to ionising radiation for 
patients and volunteers are being allayed by improved dose reduction 
techniques37,38 and a more widespread use of “very low” dose approaches39. 
These have opened the door for CT to be used in clinical and research settings. 
CT imaging has already been part of large cohort research studies such as the 
AGES-Reykjavik and Approach population studies 
(http://www.hjartarannsokn.is/index.aspx?GroupId=346; 
http://www.approachproject.eu), in which it has been used to assess different 
elements of musculoskeletal health. This means that research platforms already 
exist for exciting applications of JSM, which itself requires no special imaging 
conditions, just a routine clinical CT acquisition. Indeed, our first application study 
plans to describe the implementation and results of JSM in a subcohort of the 
AGES population with known hip disease outcomes, revealing relationships 
between 3D joint space width, hip pain, and future total hip replacement. 
Given the use of CT in clinical assessment of joint diseases such as arthritis, 
femoro-acetabular impingement, avascular necrosis, and osteochondral injury, if 
its clinical utility can been established, JSM could have an important role in 
quantification and visualisation of joint space for clinical decision making. On a 
wider scale, it could be used to screen at-risk populations for disease progression, 
such as those with known arthritis, shape disorders that predispose to accelerated 
degenerative change, or elite athletes that undertake high stress-loading activity. 
We recognise that these ideas require further investigation, but this study has 
show that JSM has the ability to provide accurate and reliable information with the 
potential to influence decisions based on the progress of disease, therapeutic 
effects, or surgical intervention. 
In conclusion, we have shown that JSM is an accurate, robust, and versatile 
technique that could be used to assess 3D joint space width distribution in 
individuals and across populations including but not limited to the hip, knee and 
ankle. Once its clinical utility has been established, this reliable CT-based 3D 
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imaging analysis technique could represent an important step forward in 
quantitative analysis of joint disease as an alternative to 2D radiographic imaging, 
with applicability in research and clinical settings. When combined with 3D 
statistical analysis, there could also be potential to accelerate therapeutic 
development in clinical trials through improved patient stratification and disease 
characterisation.  
Materials and Methods 
1. JSM technical validation  
Cadaveric sample preparation 
The decision to use cadaveric human tissue for the technical validation study 
allowed us to ensure fixed positioning between clinical CT and high resolution 
pQCT (HRpQCT) imaging of the same joint specimens, which had to be dissected 
to fit in the HRpQCT scanner FOV. This decision also removed restrictions on 
ionising radiation use, allowing otherwise unattainable spatial resolution in 
HRpQCT imaging and, if necessary, repeat exposures. This validation study was 
approved by the University of Cambridge Council of the School of Biological 
Science Human Biology Research Ethics Committee on 21 May 2013 (HBREC 
2013.09).  
Hip joints were sourced from whole cadavers donated to the Human Anatomy 
Centre, Department of Physiology, Development and Neuroscience, University of 
Cambridge, U.K., from female donors who had given ante mortem consent for the 
use of their tissue in imaging research. All samples were obtained after whole-
body embalming and dissected to include an intact right hip joint, with principal 
cuts across the superior acetabulum, lateral aspect of the pubic rami and proximal 
femoral shaft. Finer dissection keeping the hip joint intact was performed to fit 
specimens into a custom cylindrical acrylic holder (external diameter 115 mm to fit 
the HRpQCT FOV of 126 mm), allowing consistent positioning between scans and 
prolonged storage in 20% ethanol with no imaging artefact from the container. 
The only exclusion criteria was the presence of any metalwork as identified by 
subsequent imaging; as such, no hips were excluded. Donor demographics at or 
just before death were mean ± SD age of 83 ± 14.8 years, height of 1.64 ± 0.09 m 
and weight of 54 ± 12.2 kg. 
Validation imaging data acquisition 
All clinical CT imaging was performed on a 64-slice Siemens Definition AS system 
(Siemens Medical Systems, Erlangen, Germany). The acquisition was helical with 
0.8 mm pitch, 1.0 mm slice thickness, and a kVp of 80 kV. Reconstruction matrix 
was 512 x 512 wi
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thickness 1.5 mm, all clinically standard and relevant parameters. Immediate post-
processing at the imaging workstation was with the Siemens proprietary B20f 
smooth reconstruction kernel. All HRpQCT imaging was performed on a Scanco 
Xtreme CT system (Xtreme CT, Scanco Medical AG, Brüttisellen, Switzerland) 
with cone beam axial acquisition at a kVp of 60 kV. Reconstruction matrix was 
1536 x 1536 with pixel spacing 0.082 x 0.082 mm (FOV 126 mm diameter) and 
slice thickness 0.082 mm giving isotropic voxels. A proprietary bone 
reconstruction post-processing kernel was automatically applied (Scanco Medical 
AG, Brüttisellen, Switzerland). Fig. 7 shows comparison of these two acquisitions 
for the same hip. 
 
 
Fig. 7 Validation study imaging acquisitions. a Clinical CT and b HRpQCT in axial, 
coronal and sagittal planes (left to right) for the same cadaveric right hip joint. 
Note out-of-plane (coronal and sagittal) stair-stepping artefact and generalised 
blur from the wider PSF in clinical CT compared to isotropic HRpQCT. 
 
Joint space patch creation 
All post-processing steps were implemented in Stradwin 
(http://mi.eng.cam.ac.uk/~rwp/stradwin/), freely available in-house software 
developed by the Medical Imaging Group, Cambridge University Engineering 
Department, U.K.. Initial semi-automatic manual in-frame segmentation of the 
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proximal femur was performed in each slice of the clinical CT imaging (<5 minutes 
per femur). This does not need to be precise to the bone cortex and can equally 
be supplemented by automatic segmentation20,21. Shape-based interpolation with 
regularised marching tetrahedra is used to construct a triangulated mesh object of 
the proximal femur22.  
A single femur consists of many thousands of vertices, each a potential data 
sampling point. Any overlying bone within ~5 mm of the proximal femoral surface 
is automatically projected onto each mesh vertex along its normal (i.e. 
perpendicular to the mesh surface), revealing a bright patch of opposing bony 
acetabulum on the femoral head surface. The perimeter of this bright patch is the 
margin of the joint space. The “joint space patch” is then manually segmented 
along this boundary at the femoral head surface using freehand MPR review as a 
guide to deliver an curved 3D horseshoe mesh representation of the joint space at 
its femoral aspect (Fig. S1). Each patch is re-triangulated at a slightly higher 
resolution to avoid data undersampling, in this case to contain approximately 
4,000 vertices. These steps are summarised in the Results section and Fig. 1. 
3D joint space data sampling 
The principle of JSM is to use a model-based approach to de-blur clinical CT data 
and automatically measure joint space width to a precision beyond the constraints 
placed by the blur (PSF) of the imaging system. The JSM measurement algorithm 
uses a development of the cortical bone mapping algorithm originally described by 
Treece et al. for the sub-pixel accurate measurement of cortical bone thickness 
from clinical CT imaging, most recently published in 201523. We apply this with a 
double-peak model as implemented by Whitmarsh et al. in 2017 for use of cortical 
bone mapping in the presence of metal implants24.  
Initial estimation of peak cortical density is performed across the whole proximal 
femoral mesh through the data volume using an empirical model fit described in 
Treece 201523. This yields a fixed peak density value that is the constraint in the 
deconvolution process (Fig 2. dotted red line in the JSM linear profile). We also 
assume tissue in the joint space (i.e. hyaline cartilage) to have a fixed value of 35 
HU, as estimated from a region of interest (ROI) manually drawn over cartilage in 
HRpQCT imaging of a disarticulated femoral head specimen. Imaging data is then 
sampled in 3D along a line perpendicular to each joint space patch mesh vertex 
and interpolated to deliver a 1D linear density profile from across the joint space. 
Assuming the clinical CT imaging system PSF as Gaussian, an optimiser fits a 
blurred model to the interpolated line data (Fig 2. dashed red line in the JSM linear 
profile). Then model-based deconvolution is performed on the linear profile data 
using the fixed peak cortical bone and joint space density values to identify the 
edges of opposing cortical bone. Joint space width is measured as the distance 
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between the two outer bone surfaces in the deconvolution fit step model (Fig 2. 
solid red line in the JSM linear profile). 
After sampling at each vertex across the joint space patch, automatic steep 
gradient outlier removal (i.e. flattening false peaks in the joint surface) and error-
based data smoothing deliver femoral outer bone surface co-ordinates and joint 
space width values for each vertex in the original joint space patch. This allows 
creation of a mesh representation of both the femoral and acetabular joint 
surfaces that in turn define the joint space volume; the difference between the 
original joint space patch and the JSM output joint surfaces is demonstrated in Fig 
S2. These steps are summarised in Fig. 2 as the JSM (blue) pathway. Excluding 
manual in-frame segmentation, this takes less than 5 minutes for a single hip (~2 
minutes for manual patch segmentation, moments for JSM processing). 
Clinical and HRpQCT image set cross-registration 
Each HRpQCT image volume is cross-registered with its matching clinical CT 
image volume using mutual information similarity intensity based registration 
implemented in Matlab 2013a (© 1984-2013, The MathsWork, Inc.)27. It is 
important to note that the accuracy of the cross-registration step has no effect on 
JSM performance, since it is only used in the validation process. Any slight 
improvements attainable in cross-registration would only serve to reduce the 
effect of any error from this step in our validation results. The PSF of the HRpQCT 
imaging system is reported by the manufacturer as 0.089 mm 
http://www.scanco.ch/en/systems-solutions/clinical-microct/xtremect.html, 
compared to an estimated PSF of 0.87 mm in-plane and 1.00 mm out-of-plane for 
the clinical CT imaging data23. This makes a simple adaptive-threshold technique 
suitably accurate for measurement of joint space width in HRpQCT data (called 
HR-JSM)26. The same 3D imaging data sampling strategy is applied by HR-JSM 
around the joint space patch, again with interpolation of data along the sample 
line.  
Adaptive threshold measurement in HRpQCT data (HR-JSM) 
For measurement of joint space width in the HRpQCT data (HR-JSM), the peak in 
the linear density profile closest to the original mesh is assumed to be the femoral 
joint surface. A half-maximum value of the peak density is used as threshold for 
the femoral outer surface, with a search initiated outwards along the data line to 
identify the next cortical peak above this threshold. The same half-maximum 
approach is then applied to this new peak density to define the acetabular outer 
surface. Positional outliers with respect to the femoral surface and extreme value 
outliers are manually removed using a custom MATLAB GUI written by T.D.T. 
(Matlab 2013a, © 1984-2013, The MathsWork, Inc.). Both positional outliers and 
extreme value outliers are judged by eye using the GUI, which allows the user to 
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see these being removed by narrowing the limits of accepted values against visual 
review of retained data points in 3D on the mesh surface. This step removes 
technical failures from the HRpQCT data (~10%), where the HR-pQCT algorithm 
failed to identify one or both of the bone surfaces on account of low peak cortical 
density. This process is key in maintaining the quality of the gold standard data. 
Again the distance between the two outer bone surfaces is taken as the joint 
space width. These steps are summarised in Fig. 2 as the HR-JSM (orange) 
pathway. No smoothing is applied to the HRpQCT data, meaning that some 
vertices do not have a joint space width value if there is a measurement failure or 
outlier removal. 
JSM validation metrics 
Joint space width values from clinical CT and HRpQCT are now spatially co-
registered on the same joint space patch for each individual. HRpQCT data are 
limited to a 95% range to remove noise from the extremes where there are a low 
number of data values, then subtracted from clinical CT data and smoothed to 
produce a 3D colour bias map for each individual (Fig. 2 top right, blue-to-red 
data). This process is repeated for all the cadaveric hips. Global accuracy is 
calculated as the mean of clinical CT minus HRpQCT for all joint space 
measurements where vertices have a joint space width value from both, 
approximately 65,000 out of 74,000 total possible matches (~90%, with the 
remaining ~10% of HRpQCT values having been removed as outliers/failures). 
Global precision is calculated as the standard deviation of these difference values 
across all joint space measurements.  
A surface- and edge-smoothed average of the 20 clinical CT acetabular surfaces 
produced by the JSM algorithm (i.e. not by any manual segmentation) is used as 
an average joint space representation with approximately 2,300 vertices. Note 
these are not the same object as the initial joint space patches cut from the 
femoral surfaces. Each sample acetabular surface is registered to the average 
surface using a similarity transformation then a thin plate spline transformation40 
using freely available in-house software wxRegSurf 
(http://mi.eng.cam.ac.uk/~ahg/wxRegSurf/) (Fig. 8). Joint space width values are 
transferred from the acetabular surface onto the nearest vertex on the average 
surface then smoothed, meaning that all data from across the cohort can be 
presented on the single average joint surface.	Note that the average patch is only 
used as a means to display validation results from the algorithm in 3D on a 
common surface, and in this case is of no experimental consequence. 
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Fig. 8 The process of registering the average acetabular surface to sample 
acetabular surfaces. Registration of the average patch (red) onto an individual 
sample patch produced by JSM (green) with similarity then thin plate spline 
transformations using the freely available in-house wxRegSurf software. This 
process enables data from each individual to be represented on the average 
surface after nearest-neighbour mapping from the sample to the average patch. 
 
Reproducibility imaging data acquisition 
40 clinical CT imaging sets were sourced from an existing control cohort of 
volunteer female patients in Cambridge consented for use of their imaging data in 
the investigation of hip disease (FEMCO: LREC 07-H0305-61; MRC-Hip fx and 
MRC-Ageing: LREC 06/Q0108/180; MRC-Stroke: LREC 01/245; ACCT-1: LREC 
04/Q0108/257). Exclusion criteria for these studies were: dementia/cognitive 
impairment, unconsciousness, terminal illness, metastatic cancer, previous hip 
replacement (synthetic material at either hip), previous hip fracture, osteomyelitis, 
bone tumour, known history of metabolic bone disease, those taking oral 
corticosteroids, women already enrolled in a study involving x-rays. These 40 hips 
were selected to give a range of disease scores as measured in their digitally 
reconstructed radiographs10. The minimum joint space width range was 0 to 4.2 
mm, K&L score range 0 to 3 (none to moderate). The age in this subcohort was a 
mean ± SD of 66 ± 17 years.  
CT imaging was performed on a range of clinical CT scanners (Siemens 
SOMATOM Sensation 16, Siemens SOMATOM Sensation 64, Siemens 
SOMATOM Definition Flash, Siemens SOMATOM Definition AS, GE Medical 
Systems Discovery 690). This meant there were various acquisition parameters, 
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but important reconstruction parameters were a consistent matrix of 512 x 512 
covering both hips at least from superior acetabulum to below lesser trochanter, 
pixel spacing varying from 0.59 to 0.79 mm, slice thickness from 0.75 to 1.5 mm, 
and a smooth body reconstruction kernel.  
Imaging data was anonymised, and either the left or right hip randomly allocated 
for analysis (20 of each). This heterogeneity intended to reflect a non-
standardised sample in order to maximally test reproducibility between individual 
users of JSM. Manual proximal femur segmentation had already been performed 
by experienced users for a separate study investigating the effects of focal 
osteoporosis in the proximal femur28. R.H. and T.D.T. were debriefed together on 
the JSM technique, performed 10 test cases, then came together to review 
performance. Each then performed a blinded run of JSM on the same 30 hips, 
with results from each registered and transferred to the average surface. 
Reproducibility metrics 
Global mean reproducibility bias between users is calculated from the registered 
data as R.H. values minus T.D.T. values. Global 95% agreement limits are 
presented as 1.96 x SD of the reproducibility bias. Global RMSCV is calculated as 100 × (mean of all CVs), with individual CVs calculated as (SD/mean). 
reproducibility bias, limits of agreement, and RMSCVs are also presented on the 
average joint space patch to show their variation in 3D around the joint space. 
Availability of material and data 
• Stradwin is freely available to download from 
http://mi.eng.cam.ac.uk/~rwp/stradwin/ 
• wxRegsurf is freely available to download from 
http://mi.eng.cam.ac.uk/~ahg/wxRegSurf/.  
• The MATLAB_2013a GUI written by T.D.T. is freely available on request to the 
corresponding author.  
• All CT and HRpQCT imaging data from the technical validation experiment are 
anonymised but are not publicly available due to protection of patient identity 
and confidentiality; reasonable requests for sharing can be made with the 
support of the authors to the University of Cambridge Human Biology Research 
ethics committee (HBREC 2013.09), Cambridge, UK.  
• All CT imaging data from the reproducibility experiment are anonymised but 
are not publicly available due to protection of patient identity and confidentiality; 
reasonable requests for sharing can be made with the support of the authors to 
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the relevant research ethics committees: FEMCO: LREC 07-H0305-61; MRC-
Hip fx and MRC-Ageing: LREC 06/Q0108/180; MRC-Stroke: LREC 01/245; 
ACCT-1: LREC 04/Q0108/257. 
• CT imaging data used for Fig. 6a and 6c are anonymised but are not publicly 
available due to protection of patient identity and confidentiality; reasonable 
requests for sharing can be made with the support of the authors to the 
Cambridge University Hospitals NHS Foundation Trust Research and 
Development Department, Cambridge U.K.  
• CT imaging data from Fig. 6b are fully anonymised but are not publicly 
available due to protection of patient identity and confidentiality; reasonable 
requests for sharing can be made with the support of the authors to Dr Neil 
Segal, University of Kansas, U.S.A. 
• All acetabular joint space objects and their respective joint space measurement 
and measurement error data files from all experiments have been made 
available on line through Apollo, the University of Cambridge Open Access 
repository as linked to this publication (https://doi.org/10.17863/CAM.21666). 
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Supplementary Figures 
 
Fig. S1 Magnified view of joint space boundary segmentation. Magnified views of step 5 from 
Fig. 1, showing superior (top) and inferior (bottom) views of the hip joint, with the proximal 
femoral surface object displaying bright patches where there is overlying acetabular bone, as 
described in step 4. Segmentation of the joint space boundary (left) is performed in Stradwin 
using a 3D surface segmentation tool guided by freehand, user-manipulated MPR (background 
imaging data in the figure) to outline the patch. This MPR plane can be rotated around the 
femoral head to help track the boundary of the joint as it is segmented. The 3D “joint space 
patch” (yellow) is then extracted from the proximal femoral surface (right), as described in step 6. 
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Fig. S2 Comparison of the joint space patch and output surfaces. Axial plane view of the left 
hip from the same patient as in Fig. 5a (no radiological hip disease). This shows the in-plane 
outline of the original femoral surface (red), the joint space patch cut from this (yellow) and the 
JSM algorithm output joint surfaces (green). Note how the joint space patch is not the same as 
the output femoral or acetabular joint surfaces, and is only used as the basis to deliver these 
using the JSM algorithm. However, the patch is important for restricting the measurement points 
within the manually segmented joint space edge in step 5, shown as a magnified view in Fig S1.  
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Fig. S3 Scatter plot for technical validation data. Clinical CT vs HRpQCT validation data 
presented as a scatter plot, corresponding to Fig 3a but without upper and lower 2.5% data limits. 
The red dashed line of y = x is the target truth for validation (i.e. a value measured in 1.5 mm CT 
equals that measured in HRpQCT). 
 
 
